Intensity Therapeutics Inc (NASDAQ:INTS) does about 495.00K shares in volume on a normal day but saw 4386296 shares change hands in the recent trading day. The company now has a market cap of 10.87M USD. Its current market price is $0.59, marking an increase of 24.37% compared to the previous close of $0.48. The 52 week high reached by this stock is $5.10 whilst the lowest price level in 52 weeks is $0.29. The script in recent trading has seen the stock touch a high of $5 and a low of $5.
The consensus objective for the share price is $5.75, suggesting that the stock has a potential upside of 89.74% over the period. The median price target is 88.2% away from the current levels at $5.
The current price level is 28.38%, -48.89%, and -76.33% away from its SMA20, SMA50, and SMA200 respectively, with the INTS price moving above the 50-day SMA on current market day. Intensity Therapeutics Inc (INTS) stock is up 86.02% over the week and 5.72% over the past month. Its price is -66.42% year-to-date and -87.79% over the past year.
Its 12-month price target is $5. To reach the target analysts have set, the stock logically needs to grow 89.74 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $5, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $5.
Outstanding shares total 15.26M with insiders holding 33.62% of the shares and institutional holders owning 14.16% of the company’s common stock. The company has a return on investment of -3443.12% and return on equity of -298.57%. The beta has a value of 4.25. Price to book ratio is 27.01.
